{
  "case_id": "case_0011",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 32.47,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- left optic nerve and left midbrain.",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)",
          "left midbrain"
        ],
        "ft_lesions_parsed": [
          {
            "location": "midbrain",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left midbrain",
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD and Neurosarcoid.\n\nOther possible differentials:\n- SLE and Neurosyphilis.\n- Also feasible but of low probability: Lyme, TB, Leptomeningeal carcinomatosis, Vasculitis, Sjogren's, ADEM, Beh\u00e7et's and Lymphoma.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Left paramedian midbrain infarction (posterior circulation ischaemic stroke) with concurrent left optic neuropathy (technically feasible explanation for all signs, but proposes multiple separate pathologies; less parsimonious than a unifying diagnosis)\n- Intrinsic left midbrain neoplasm (e.g., glioma) with optic pathway involvement (plausible for unilateral brainstem; but atypical for unilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting multiple sclerosis with left midbrain plaque and left optic neuritis",
          "Neuromyelitis optica spectrum disorder",
          "MOG-antibody associated disease",
          "Left paramedian midbrain infarction (posterior circulation ischaemic stroke) with concurrent left optic neuropathy",
          "Intrinsic left midbrain neoplasm (e.g., glioma) with optic pathway involvement",
          "Inflammatory or granulomatous brainstem disease (e.g., neurosarcoidosis, autoimmune brainstem encephalitis)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "MS",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MOGAD"
        ],
        "missing_lesion_dx_keys": [
          "Infection_Lyme",
          "CNS_Tuberculosis",
          "Syphilis",
          "Leptomeningeal_Carcinomatosis",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "ADEM",
          "Autoimmune_Myelitis_SLE",
          "Behcet_Disease",
          "CNS_Lymphoma"
        ],
        "missing_common_names": [
          "Neurosyphilis",
          "SLE"
        ],
        "missing_low_prob_names": [
          "Lyme",
          "TB",
          "Leptomeningeal carcinomatosis",
          "Vasculitis",
          "Sjogren's",
          "ADEM",
          "Beh\u00e7et's",
          "Lymphoma"
        ],
        "additional_diagnoses": [
          "Left paramedian midbrain infarction (posterior circulation ischaemic stroke) with concurrent left optic neuropathy",
          "Intrinsic left midbrain neoplasm (e.g., glioma) with optic pathway involvement"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 2,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 14,
        "lesion_ddx_matched_count": 4,
        "lesion_ddx_missed_common_count": 2,
        "lesion_ddx_missed_low_prob_count": 8,
        "lesion_ddx_coverage_percentage": 0.2857142857142857
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-dsDNA, anti-MOG, ANA, CRP, anti-AQP4, ENA, ACE, HIV, ANCA, syphilis, ESR, lyme.\n- Could also consider testing: TB, CSF (flow cytometry and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium contrast",
          "MRI of whole spine with gadolinium contrast",
          "MR angiogram of intracranial and neck vessels",
          "Visual evoked potentials",
          "Optical coherence tomography of retinal nerve fibre layer",
          "Lumbar puncture for CSF cell count and differential",
          "Lumbar puncture for CSF protein and glucose",
          "Lumbar puncture for CSF oligoclonal bands and IgG index",
          "Lumbar puncture for CSF microbiology and viral PCR as indicated",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Coagulation screen",
          "Blood glucose",
          "Lipid profile",
          "Vitamin B12 level",
          "Serum folate level",
          "Thyroid function tests",
          "Serum ACE level",
          "Antinuclear antibody",
          "Extractable nuclear antigen antibody panel",
          "Anti-double-stranded DNA antibody",
          "ANCA (antineutrophil cytoplasmic antibodies)",
          "Serum aquaporin-4 (AQP4) antibody",
          "Serum MOG (myelin oligodendrocyte glycoprotein) antibody",
          "HIV serology",
          "Syphilis serology",
          "Lyme disease serology (if epidemiologically indicated)",
          "Electrocardiogram",
          "Chest X-ray"
        ],
        "all_identified_ft_keys": [
          "Anti_dsDNA",
          "Lipid_Profile",
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "CSF_Viral_PCR",
          "Coagulation_Screen",
          "MRI_Orbits",
          "LFT",
          "ENA_Panel",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ECG",
          "CSF_General",
          "Lyme_Serology",
          "FBC",
          "ANA",
          "MRI_Whole_Spine",
          "OCT",
          "MRI_Lumbosacral_Spine",
          "Cerebral_Angiography",
          "MRI_Cervical_Spine",
          "Folate",
          "Chest_XRay",
          "MRI_Thoracic_Spine",
          "ANCA",
          "HIV_Test",
          "MRA_Head_Neck",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "MOG_Antibodies",
          "CRP",
          "ANA",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "missing_inv_keys_ddx": [
          "CSF_Flow_Cytometry",
          "TB_Screen",
          "CSF_Cytology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 15,
        "ddx_tests_found_count": 12,
        "ddx_tests_coverage_percentage": 0.8
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Subacute severe brainstem and optic nerve deficits are highly suggestive of an inflammatory demyelinating relapse",
              "Early corticosteroids accelerate recovery and reduce duration of neurological disability",
              "To be commenced immediately after MRI excludes compressive mass or intracranial haemorrhage"
            ]
          },
          {
            "treatment": "Oral prednisolone taper for 1\u20132 weeks after intravenous steroids",
            "timing": "Delay",
            "reasons": [
              "Introduced after completing IV methylprednisolone to prevent rebound symptoms",
              "Dosing and duration depend on response, comorbidities and glucose control"
            ]
          },
          {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (e.g., interferon beta, glatiramer acetate or higher-efficacy agent per MS specialist advice)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of demyelinating disease by MRI and CSF studies and exclusion of mimics",
              "Choice of agent must be individualised based on relapse severity, lesion burden and patient factors",
              "Usually started after the acute relapse has stabilised"
            ]
          },
          {
            "treatment": "Antiplatelet therapy with aspirin 300 mg daily and subsequent maintenance dosing if ischaemic stroke is confirmed and no contraindications",
            "timing": "Delay",
            "reasons": [
              "Stroke remains a differential but cannot be assumed without neuroimaging and CSF results",
              "Starting antiplatelets before excluding haemorrhage or inflammatory demyelination may be harmful"
            ]
          },
          {
            "treatment": "Neurosurgical or interventional neuroradiology referral for decompression or aneurysm treatment if a compressive or vascular lesion is identified",
            "timing": "Delay",
            "reasons": [
              "Indicated only if imaging demonstrates a surgically or endovascularly treatable cause (e.g., tumour, cavernoma, aneurysm)",
              "Definitive structural treatment must follow accurate anatomical and aetiological diagnosis"
            ]
          },
          {
            "treatment": "Physiotherapy and occupational therapy for gait ataxia and right-sided weakness",
            "timing": "Start Now",
            "reasons": [
              "Early multidisciplinary rehabilitation improves functional outcome and independence",
              "Patient already exhibits unsteady gait and right hemiparesis with high falls risk"
            ]
          },
          {
            "treatment": "Deep vein thrombosis prophylaxis with low-molecular-weight heparin and graduated compression stockings",
            "timing": "Start Now",
            "reasons": [
              "Hemiparesis and reduced mobility significantly increase venous thromboembolism risk",
              "Prophylaxis is standard in immobilised neurological inpatients absent contraindications"
            ]
          },
          {
            "treatment": "Proton pump inhibitor and blood glucose monitoring during high-dose steroid therapy",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroids increase risk of gastrointestinal bleeding and hyperglycaemia",
              "Preventive measures should be instituted concurrently with steroid therapy"
            ]
          },
          {
            "treatment": "Visual rehabilitation and symptomatic management of diplopia or visual field impairment (e.g., eye patch, prisms, orthoptic referral)",
            "timing": "Delay",
            "reasons": [
              "Best organised after the acute phase when neurological deficits have stabilised",
              "Aims to optimise functional vision and quality of life during recovery"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Subacute severe brainstem and optic nerve deficits are highly suggestive of an inflammatory demyelinating relapse",
              "Early corticosteroids accelerate recovery and reduce duration of neurological disability",
              "To be commenced immediately after MRI excludes compressive mass or intracranial haemorrhage"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (e.g., interferon beta, glatiramer acetate or higher-efficacy agent per MS specialist advice)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of demyelinating disease by MRI and CSF studies and exclusion of mimics",
              "Choice of agent must be individualised based on relapse severity, lesion burden and patient factors",
              "Usually started after the acute relapse has stabilised"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 3,
          "reasons_acknowledged": 0,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 4,
          "reasons_acknowledged": 1,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.25
        }
      }
    }
  }
}